Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

Conditions:   Safety of a Single Dose of COMVIGEN Vaccine;   Reactogenicity of a Single Dose of COMVIGEN Vaccine;   Immunogenicity of a Single Dose of COMVIGEN Vaccine;   Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine;   Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine;   Imm unogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine Interventions:   Biological: Comvigen (Bivalent, ChulaCov19 BNA159.2);   Biological: BIVALENT Pfizer/BNT vaccine Sponsors:   Chulalongkorn University;   Chula Clinical Research Center (Chula CRC), Faculty of Medicine Chulalongkorn University, Bangkok, Thailand;   HIV-NAT, Thai Red Cross - AIDS Research Centre Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials